Introduction
Flunixin Meglumine is a nonsteroidal anti-inflammatory drug (NSAID) widely used in veterinary medicine for its analgesic, anti-inflammatory, and antipyretic properties. It exerts its pharmacological effects primarily by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the synthesis of prostaglandins involved in pain, fever, and inflammation. Flunixin Meglumine is commonly administered to cattle, horses, and swine to manage musculoskeletal pain, colic, and endotoxemia. Its well-characterized mechanism of action, solubility as a meglumine salt, and established safety profile make it valuable for veterinary pharmacology research and therapeutic applications.
COA
Publication 
Loading ......
